ロード中...
Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems
Infections caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria are associated with worse outcomes and have limited treatment options. Carbapenems remain the drug of choice for these infections due to evidence of a mortality benefit and the mixed clinical efficacy associated with pip...
保存先:
| 出版年: | Proc (Bayl Univ Med Cent) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6541085/ https://ncbi.nlm.nih.gov/pubmed/31191124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1582466 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|